↓ Skip to main content

Dove Medical Press

Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab

Overview of attention for article published in Therapeutics and Clinical Risk Management, August 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

patent
1 patent

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
56 Mendeley
Title
Targeting p19 as a treatment option for psoriasis: an evidence-based review of guselkumab
Published in
Therapeutics and Clinical Risk Management, August 2018
DOI 10.2147/tcrm.s177127
Pubmed ID
Authors

Todd Wechter, Abigail Cline, Steven R Feldman

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 56 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 16%
Researcher 9 16%
Student > Ph. D. Student 7 13%
Student > Bachelor 5 9%
Student > Doctoral Student 4 7%
Other 9 16%
Unknown 13 23%
Readers by discipline Count As %
Medicine and Dentistry 27 48%
Immunology and Microbiology 6 11%
Pharmacology, Toxicology and Pharmaceutical Science 2 4%
Agricultural and Biological Sciences 2 4%
Computer Science 2 4%
Other 2 4%
Unknown 15 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 October 2020.
All research outputs
#8,538,940
of 25,385,509 outputs
Outputs from Therapeutics and Clinical Risk Management
#461
of 1,323 outputs
Outputs of similar age
#136,104
of 341,886 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#13
of 35 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 341,886 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.